222 related articles for article (PubMed ID: 29405696)
1. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
[TBL] [Abstract][Full Text] [Related]
2. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
3. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
4. A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.
Capul AA; de la Torre JC
Virology; 2008 Dec; 382(1):107-14. PubMed ID: 18929379
[TBL] [Abstract][Full Text] [Related]
5. Reverse genetics approaches to combat pathogenic arenaviruses.
de la Torre JC
Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
de la Torre JC
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
[TBL] [Abstract][Full Text] [Related]
7. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
Kim YJ; Cubitt B; Chen E; Hull MV; Chatterjee AK; Cai Y; Kuhn JH; de la Torre JC
Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
[TBL] [Abstract][Full Text] [Related]
8. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
9. Arenavirus extinction through lethal mutagenesis.
de la Torre JC
Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
Vázquez-Calvo Á; Martín-Acebes MA; Sáiz JC; Ngo N; Sobrino F; de la Torre JC
Antiviral Res; 2013 Aug; 99(2):172-9. PubMed ID: 23735299
[TBL] [Abstract][Full Text] [Related]
12. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
Iwasaki M; Ngo N; Cubitt B; Teijaro JR; de la Torre JC
J Virol; 2015 Dec; 89(23):12166-77. PubMed ID: 26401045
[TBL] [Abstract][Full Text] [Related]
13. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.
Urata S; Yun N; Pasquato A; Paessler S; Kunz S; de la Torre JC
J Virol; 2011 Jan; 85(2):795-803. PubMed ID: 21068251
[TBL] [Abstract][Full Text] [Related]
15. Sodium hydrogen exchangers contribute to arenavirus cell entry.
Iwasaki M; Ngo N; de la Torre JC
J Virol; 2014 Jan; 88(1):643-54. PubMed ID: 24173224
[TBL] [Abstract][Full Text] [Related]
16. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
[TBL] [Abstract][Full Text] [Related]
17. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
[TBL] [Abstract][Full Text] [Related]
18. Novel antiviral strategies to combat human Arenavirus infections.
Kunz S; de la Torre JC
Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
[TBL] [Abstract][Full Text] [Related]
19. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
[TBL] [Abstract][Full Text] [Related]
20. Arenavirus Quasispecies and Their Biological Implications.
Grande-Pérez A; Martin V; Moreno H; de la Torre JC
Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
